The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
type 1 is approximately one in 300 people and the typical age of onset is around nine and they live into adulthood and and many so into their 80s or even 90s they have of course reduce survival because of complications but it's an incredibly common illness it's the most common life-threatening medication requiring illness of childhood
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.